27 related articles for article (PubMed ID: 30768441)
1. Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
Prost DM; Merenzon MA; Gómez-Escalante JI; Primavera A; Vargas Benítez M; Gil AS; Marenco PM; Califano MM; Moughty Cueto C; Zaloff Dakoff JM; Colonna M; Mazzón A; Zaninovich RS; De Cristófaro OR
PLoS One; 2021; 16(4):e0249486. PubMed ID: 33798233
[TBL] [Abstract][Full Text] [Related]
2. The impact of radiation therapy variables on pediatric high-grade glioma outcomes: A National Cancer Database analysis.
Williamson C; Williamson S; Jiang R; Sudmeier L; Esiashvili N; Eaton BR
Pediatr Blood Cancer; 2024 Jan; 71(1):e30751. PubMed ID: 37937991
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Bell EH; Zhang P; Shaw EG; Buckner JC; Barger GR; Bullard DE; Mehta MP; Gilbert MR; Brown PD; Stelzer KJ; McElroy JP; Fleming JL; Timmers CD; Becker AP; Salavaggione AL; Liu Z; Aldape K; Brachman DG; Gertler SZ; Murtha AD; Schultz CJ; Johnson D; Laack NN; Hunter GK; Crocker IR; Won M; Chakravarti A
J Clin Oncol; 2020 Oct; 38(29):3407-3417. PubMed ID: 32706640
[TBL] [Abstract][Full Text] [Related]
4. Effect of radiation therapy on overall survival following subtotal resection of adult pilocytic astrocytoma.
Khalafallah AM; Jimenez AE; Shah PP; Brem H; Mukherjee D
J Clin Neurosci; 2020 Nov; 81():340-345. PubMed ID: 33222942
[TBL] [Abstract][Full Text] [Related]
5. An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores.
Pérez IF; Valverde D; Valverde CF; Iglesias JB; Silva MJV; Quintela ML; Meléndez B
Sci Rep; 2022 Sep; 12(1):16433. PubMed ID: 36180501
[TBL] [Abstract][Full Text] [Related]
6. Biopsy versus resection for the management of low-grade gliomas.
Jiang B; Chaichana K; Veeravagu A; Chang SD; Black KL; Patil CG
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009319. PubMed ID: 28447767
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
Moreno AC; Haque W; Verma V; Fang P; Lin SH
Ann Surg Oncol; 2018 May; 25(5):1245-1253. PubMed ID: 29484562
[TBL] [Abstract][Full Text] [Related]
8. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer.
Verma V; Moreno AC; Haque W; Fang P; Lin SH
J Natl Compr Canc Netw; 2018 May; 16(5):508-516. PubMed ID: 29752325
[No Abstract] [Full Text] [Related]
9. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
[TBL] [Abstract][Full Text] [Related]
10. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
11. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ; Bindra RS; Contessa JN; Patel KR
Anticancer Res; 2019 Jun; 39(6):2911-2918. PubMed ID: 31177129
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria.
Ryckman JM; Appiah AK; Lyden E; Verma V; Zhang C
Am J Clin Oncol; 2019 Apr; 42(4):391-398. PubMed ID: 30768441
[TBL] [Abstract][Full Text] [Related]
13. Prospective clinical trials of intracranial low-grade glioma in adults and children.
Shaw EG; Wisoff JH
Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
